Literature DB >> 7389185

Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus.

J Hananian, J E Cleaver.   

Abstract

A patient is described who has a unique combination of symptoms that correspond with two sun-sensitive conditions: xeroderma pigmentosum (XP) and systemic lupus erythematosus (SLE). Both of these conditions have been suggested as being associated with a defect in DNA repair, but this is only clearly established for XP. The patient described is the only known case among U.S. blacks, thus far, although African black cases are known. Her DNA repair levels are 20--30% of normal, within the range found for many XP cell cultures and consistent with her assignment to group C by other investigators. Unusual for group C cases, however, are the neurological disorders, some of which correspond to those found in the de Sanctis Cacchione form of XP, which is commonly assigned to group A. Whether the associated SLE is a consequence of some special aspect of this particular XP condition or whether it is fortuitous cannot be resolved at present.

Entities:  

Mesh:

Year:  1980        PMID: 7389185     DOI: 10.1111/j.1399-0004.1980.tb00112.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.

Authors:  Jennifer Pugh; Sikandar G Khan; Deborah Tamura; Alisa M Goldstein; Maria Teresa Landi; John J DiGiovanna; Kenneth H Kraemer
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Diagnosis of Xeroderma Pigmentosum and Related DNA Repair-Deficient Cutaneous Diseases.

Authors:  James E Cleaver
Journal:  Curr Med Lit Dermatol       Date:  2008

3.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 4.  Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.

Authors:  James E Cleaver; Ernest T Lam; Ingrid Revet
Journal:  Nat Rev Genet       Date:  2009-10-07       Impact factor: 53.242

5.  Enhanced expression of procollagenase in ataxia-telangiectasia and xeroderma pigmentosum fibroblasts.

Authors:  J Aggeler; J P Murnane
Journal:  In Vitro Cell Dev Biol       Date:  1990-09

6.  Hypoglycinaemia and psychomotor delay in a child with xeroderma pigmentosum.

Authors:  E J Quackenbush; K H Kraemer; W A Gahl; V Schirch; D A Whiteman; K Levine; H L Levy
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

7.  XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Authors:  Sikandar G Khan; Kyu-Seon Oh; Steffen Emmert; Kyoko Imoto; Deborah Tamura; John J Digiovanna; Tala Shahlavi; Najealicka Armstrong; Carl C Baker; Marcy Neuburg; Chris Zalewski; Carmen Brewer; Edythe Wiggs; Raphael Schiffmann; Kenneth H Kraemer
Journal:  DNA Repair (Amst)       Date:  2008-11-14

8.  Mechanism of photosensitivity in systemic lupus erythematosus patients.

Authors:  I Emerit; A M Michelson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.

Authors:  Karina Miranda Santiago; Amanda França de Nóbrega; Rafael Malagoli Rocha; Silvia Regina Rogatto; Maria Isabel Achatz
Journal:  Int J Mol Sci       Date:  2015-04-22       Impact factor: 5.923

10.  A human XPC protein interactome--a resource.

Authors:  Abigail Lubin; Ling Zhang; Hua Chen; Victoria M White; Feng Gong
Journal:  Int J Mol Sci       Date:  2013-12-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.